Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam

Completed · Phase 4

Conditions studied: Major Depressive Disorder

In brief

The main purpose of this study is to evaluate the effect of desvenlafaxine administered as DVS SR on the pharmacokinetics of midazolam in healthy male and female subjects. The amount of drug in the body and the effect of the drug will also be evaluated.

Key facts

Study ID
NCT00952653
Run by
Pfizer
People needed
28
Starts
2010-06-01
Expected to finish
2010-08-01
Last updated by the study team
2011-08-15

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.